Allogene Therapeutics
Maddie Goldstein is a Senior Manager of Corporate Communications at Allogene Therapeutics, with experience that includes roles such as Manager of Corporate and Pipeline Communications. Prior to this, Maddie held the position of Account Manager and Account Associate at W2O Group, focusing on healthcare clients and handling corporate and product announcements, media strategies, and client reports. Additional experience includes an Account Intern position at Boomtown Accelerator, where support was provided to early-stage startups, and a Production Assistant/Social Media Manager role at USA Talk Network's "The Aaron Harber Show," which involved social media management and research. Maddie is an alumna of the University of Colorado Boulder and Saint Ignatius College Preparatory.
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.